Potential of ceramide 1-phosphate as a novel therapeutic agent in pulmonary inflammation

Expert Rev Clin Pharmacol. 2016;9(5):629-31. doi: 10.1586/17512433.2016.1152181. Epub 2016 Feb 24.

Authors

Ana Gomez-Larrauri¹, Miguel Trueba², Antonio Gomez-Muñoz²

Affiliations

¹ a Department of Pneumology , University Hospital of Alava (Osakidetza) , Vitoria-Gasteiz , Spain.
² b Department of Biochemistry and Molecular Biology, Faculty of Science and Technology , University of the Basque Country (UPV/EHU) , Bilbao , Spain.

PMID: 26855208
DOI: 10.1586/17512433.2016.1152181

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Anti-Inflammatory Agents / pharmacology*
Ceramides / pharmacology*
Humans
Inflammation / drug therapy*
Inflammation / etiology*
Lung Diseases / drug therapy*
Lung Diseases / etiology
Smoke / adverse effects
Tobacco Products / toxicity

Substances

Anti-Inflammatory Agents
Ceramides
Smoke
ceramide 1-phosphate